CTOR vs MKC · $105.2M cap vs P/E 8.4, $13.56B cap
Citius Oncology, Inc. (CTOR) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
CTOR does not have a complete income-statement cache yet.
MKC does not have a complete income-statement cache yet.
CTOR currently screens at market cap $105.2M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the CTOR and MKC stock pages for the full models.
Not investment advice.